HNW
CLB icon

High Note Wealth’s Core Laboratories CLB Stock Holding History

High Note Wealth’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.73K Buy
492
+375
+321% +$5.35K ﹤0.01% 548
2026
Q1 		$1.96K Hold
117
– – ﹤0.01% 789
2025
Q4 		$1.88K Sell
117
-80
-41% -$1.19K ﹤0.01% 779
2025
Q3 		$2.44K Buy
197
+13
+7% +$152 ﹤0.01% 647
2025
Q2 		$2.12K Sell
184
-93
-34% -$1.1K ﹤0.01% 639
2025
Q1 		$4.15K Buy
277
+23
+9% +$385 ﹤0.01% 498
2024
Q4 		$4.4K Buy
+254
New +$4.9K ﹤0.01% 498

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

High Note Wealth's CLB Position: Q2 2026 in Review

High Note Wealth increased its Core Laboratories (CLB) stake by 321% in Q2 2026, buying an estimated $5.35K and bringing the position to 492 shares worth $5.73K. The position accounts for ﹤0.01% of the portfolio, ranked #548.

High Note Wealth first reported a position in CLB in Q4 2024 and has held it in 7 quarters since. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • High Note Wealth held 492 shares of Core Laboratories worth $5.73K as of Q2 2026.
  • High Note Wealth bought 375 Core Laboratories shares in Q2 2026, an estimated $5.35K.
  • Core Laboratories made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #548 holding.
  • High Note Wealth first reported a position in Core Laboratories in Q4 2024 and has held it in 7 quarters since.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.